All of the following statements concerning Atrial Natriuretic Peptide (ANP) are true EXCEPT?
Uremia occurs when the total GFR is reduced by approximately what percentage?
Which test is used for estimating kidney function?
What is the primary site of action of Antidiuretic Hormone (ADH)?
In which part of the Henle loop is the tubular fluid hypotonic with plasma/GFR?
PAH is used to measure which physiological parameter?
Which of the following activates vanilloid receptors in the urinary bladder?
Where is bicarbonate absorbed?
Which cells in the kidney have a secretory function?
In urinary system disease, gastrointestinal symptoms appear because of which of the following mechanisms?
Explanation: **Explanation:** Atrial Natriuretic Peptide (ANP) is a powerful hormone secreted by the atrial myocytes in response to atrial stretch, serving as the body’s natural defense against fluid overload. **Why Option D is the correct answer (The Exception):** The cellular mechanism of ANP involves binding to its receptor (NPR-A), which has intrinsic **guanylyl cyclase** activity. This leads to the conversion of GTP to **cyclic GMP (cGMP)**, not cAMP. cGMP then activates protein kinase G (PKG) to mediate vasodilation and natriuresis. **Analysis of Incorrect Options:** * **Option A:** ANP is secreted in response to **increased blood volume** or pressure, which causes atrial wall stretch (mechanoreceptor activation). * **Option B:** ANP **increases GFR** through a "push-pull" mechanism: it dilates the afferent arteriole and constricts the efferent arteriole. This increases the glomerular capillary hydrostatic pressure. * **Option C:** ANP acts as an antagonist to the Renin-Angiotensin-Aldosterone System (RAAS). It **inhibits renin secretion** from juxtaglomerular cells and directly inhibits aldosterone secretion from the adrenal cortex. **High-Yield Clinical Pearls for NEET-PG:** * **Site of Action:** ANP primarily acts on the **medullary collecting ducts** to inhibit Na+ reabsorption. * **Brain Natriuretic Peptide (BNP):** Secreted by ventricles; used clinically as a marker for **Heart Failure** (high sensitivity). * **Neprilysin:** The enzyme that degrades ANP/BNP. Neprilysin inhibitors (e.g., Sacubitril) are now used in heart failure management to prolong the beneficial effects of natriuretic peptides. * **Mnemonic:** ANP = **A**fferent **N**early **P**atent (Dilates), **E**fferent **E**xtremely **E**nded (Constricts).
Explanation: **Explanation:** The correct answer is **25% (Option A)**. This question tests the understanding of the kidney's functional reserve and the progression of Chronic Kidney Disease (CKD). **1. Why 25% is correct:** The kidneys possess a massive functional reserve. Clinical symptoms of **uremia** (a syndrome caused by the accumulation of nitrogenous waste products like urea and creatinine) typically do not manifest until the total Glomerular Filtration Rate (GFR) falls below **25% of its normal value** (roughly <30 mL/min/1.73m²). At this stage, the remaining functional nephrons can no longer compensate for the loss, leading to systemic toxicity, electrolyte imbalances, and fluid overload. **2. Why the other options are incorrect:** * **50% (Option B):** When GFR is reduced by 50%, the patient is often asymptomatic. This is seen in individuals who donate a kidney; the remaining kidney undergoes compensatory hypertrophy, and the patient does not develop uremia. * **60% (Option C):** A 60% reduction (leaving 40% function) corresponds to Stage 3 CKD. While biochemical abnormalities (like mild anemia or secondary hyperparathyroidism) may begin, overt uremic symptoms are rare. * **80% (Option D):** While uremia is certainly present at an 80% reduction (leaving 20% function), the question asks for the threshold at which it *occurs*. Uremia begins to manifest earlier, around the 25% functional mark. **High-Yield Clinical Pearls for NEET-PG:** * **Stages of CKD:** Stage 1 (>90 GFR), Stage 2 (60-89), Stage 3 (30-59), Stage 4 (15-29), Stage 5 (<15 or Dialysis). * **Uremic Frost:** A late clinical sign where urea crystallizes on the skin. * **Most common cause of death in Uremia:** Cardiovascular disease (not renal failure itself). * **First sign of CKD:** Often microalbuminuria, rather than a drop in GFR.
Explanation: **Explanation:** The **Inulin clearance test** is considered the **Gold Standard** for measuring the Glomerular Filtration Rate (GFR) and estimating kidney function. **Why Inulin?** Inulin is an exogenous polysaccharide that fulfills all the criteria for an ideal GFR marker: 1. It is **freely filtered** by the glomeruli. 2. It is **neither reabsorbed nor secreted** by the renal tubules. 3. It is not metabolized or stored in the kidney. Therefore, the amount of inulin filtered is equal to the amount excreted in the urine, making its clearance rate exactly equal to the GFR. **Analysis of Other Options:** * **A. Serum Creatinine:** While commonly used in clinical practice to *estimate* GFR (eGFR), it is not the most accurate method. Creatinine is freely filtered but also **secreted** by the proximal tubules (approx. 10–15%), which leads to an overestimation of the actual GFR. * **B. Serum Phosphatase:** This is a marker used to assess bone metabolism (Alkaline Phosphatase) or prostate health (Acid Phosphatase); it has no role in measuring renal filtration. * **D. Insulin Clearance Test:** This is a common **distractor** in exams. Insulin is a hormone involved in glucose regulation, not a marker for renal clearance. **High-Yield Clinical Pearls for NEET-PG:** * **GFR Formula:** $C = (U \times V) / P$ (where U = Urine concentration, V = Urine flow rate, P = Plasma concentration). * **Creatinine Clearance:** The most common endogenous marker used clinically. * **Para-amino hippuric acid (PAH) Clearance:** Used to measure **Effective Renal Plasma Flow (ERPF)** because it is both filtered and completely secreted. * **Normal GFR:** Approximately 125 mL/min.
Explanation: **Explanation:** The primary site of action for **Antidiuretic Hormone (ADH)**, also known as Vasopressin, is the **Collecting Ducts** (specifically the principal cells) and the late distal tubule. **Why D is correct:** ADH acts on **V2 receptors** located on the basolateral membrane of the collecting duct cells. This triggers a cAMP-mediated signaling pathway that leads to the insertion of **Aquaporin-2 (AQP2)** water channels into the apical membrane. This increases the water permeability of the otherwise impermeable duct, allowing water to be reabsorbed down the osmotic gradient into the medullary interstitium, resulting in concentrated urine. **Why the other options are incorrect:** * **A. Proximal Convoluted Tubule (PCT):** This is the site of obligatory water reabsorption (65-70%), which occurs independently of ADH via Aquaporin-1. * **B. Vasa recta:** These are peritubular capillaries that maintain the medullary osmotic gradient via a countercurrent exchange mechanism; they do not serve as the target for ADH-mediated water transport. * **C. Loop of Henle:** The thick ascending limb is the "diluting segment" and is always impermeable to water. ADH does not act here to increase water permeability, though it may subtly enhance NaCl reabsorption. **High-Yield Clinical Pearls for NEET-PG:** * **V1 Receptors:** Located on vascular smooth muscle; cause vasoconstriction (IP3/DAG pathway). * **Diabetes Insipidus (DI):** Central DI is due to ADH deficiency; Nephrogenic DI is due to renal resistance to ADH (often V2 receptor mutations or Lithium toxicity). * **SIADH:** Characterized by excessive ADH, leading to dilutional hyponatremia and highly concentrated urine. * **Urea Recycling:** ADH also increases the permeability of the **medullary** collecting ducts to urea (via UT-A1 transporters), which helps maintain the hypertonic medullary gradient.
Explanation: **Explanation:** The tonicity of tubular fluid changes significantly as it traverses the Loop of Henle due to the differential permeability of its segments. **Correct Answer: C. Thick Ascending Limb (TAL)** The TAL is known as the **"Diluting Segment"** of the nephron. It is characterized by being **impermeable to water** but actively reabsorbing solutes (Na⁺, K⁺, and Cl⁻) via the **NKCC2 transporter**. As electrolytes are pumped out into the medullary interstitium while water remains trapped in the tubule, the tubular fluid becomes increasingly dilute. By the time the fluid reaches the end of the TAL and enters the distal convoluted tubule, it is significantly **hypotonic** (approx. 100–150 mOsm/L) compared to plasma (approx. 300 mOsm/L). **Why other options are incorrect:** * **A. Thin Descending Limb:** This segment is highly permeable to water but impermeable to solutes. As it descends into the hypertonic medulla, water leaves the tubule, making the fluid **hypertonic**. * **B. Thin Ascending Limb:** While solute reabsorption begins here passively, the fluid only starts moving toward isotonicity from a highly concentrated state. It does not become hypotonic until it reaches the thick portion where active transport occurs. * **D. Thick Descending Limb:** This is part of the proximal straight tubule. The fluid here remains largely **isotonic** to plasma as water and solutes are reabsorbed proportionately. **High-Yield Facts for NEET-PG:** * **NKCC2 Transporter:** The target of **Loop Diuretics** (e.g., Furosemide), which act in the TAL. * **Countercurrent Multiplier:** The TAL provides the osmotic gradient necessary for the kidney to concentrate urine. * **Bartter Syndrome:** A genetic defect in the NKCC2 transporter or associated channels in the TAL, mimicking chronic loop diuretic use.
Explanation: **Explanation:** Para-aminohippuric acid (PAH) is the gold standard for measuring **Renal Plasma Flow (RPF)** because it undergoes both glomerular filtration and extensive tubular secretion. Approximately 90% of PAH is removed from the blood in a single pass through the kidneys. Since it is almost completely cleared from the renal plasma, its clearance rate equals the effective renal plasma flow (eRPF). **Analysis of Options:** * **Option A (Extracellular fluid volume):** Measured using substances that distribute throughout the ECF but do not enter cells, such as **Inulin, Mannitol, or Sucrose**. * **Option B (Glomerular filtration rate):** Measured using substances that are freely filtered but neither secreted nor reabsorbed. **Inulin** is the gold standard; **Creatinine** is used clinically. * **Option D (Plasma electrolyte concentration):** Measured via flame photometry or ion-selective electrodes, not by clearance studies. **High-Yield Clinical Pearls for NEET-PG:** * **Fick’s Principle:** The clearance of PAH is used to calculate RPF. To find **Renal Blood Flow (RBF)**, use the formula: $RBF = RPF / (1 - Hematocrit)$. * **Extraction Ratio:** PAH is not 100% cleared because some blood supplies non-secreting portions of the kidney (like the medulla and capsule). The extraction ratio of PAH is typically **0.9**. * **Saturation Kinetics:** At very high plasma concentrations, the transporters for PAH secretion become saturated ($T_{max}$), and PAH clearance will then underestimate RPF, approaching the GFR instead. * **Filtration Fraction (FF):** Calculated as $GFR / RPF$. Normal value is approximately **20%**.
Explanation: **Explanation:** The correct answer is **Temperature**. **1. Why Temperature is Correct:** Vanilloid receptors, specifically the **TRPV1 (Transient Receptor Potential Vanilloid 1)** subtype, are non-selective cation channels found on the sensory (afferent) nerve endings of the urinary bladder mucosa and detrusor muscle. These receptors are primarily known as **polymodal nociceptors**. In the bladder, they are activated by **noxious heat (temperature >43°C)**, protons (acidic pH), and capsaicin. They play a crucial role in sensing bladder irritation and pain, contributing to the "burning" sensation during cystitis and the signaling of bladder fullness. **2. Why the Other Options are Incorrect:** * **Vibration and Touch (B & C):** These sensations are mediated by mechanoreceptors such as Pacinian corpuscles and Meissner’s corpuscles, respectively. They are not the primary function of vanilloid receptors. * **Pressure (D):** Bladder wall tension and pressure (distension) are primarily sensed by **mechanosensitive ion channels** (like Piezo channels) and high-threshold mechanoreceptors. While TRPV1 may modulate the threshold of these responses, pressure is not the direct activator of the vanilloid receptor itself. **3. High-Yield Clinical Pearls for NEET-PG:** * **Capsaicin & Resiniferatoxin:** These are TRPV1 agonists. Intravesical instillation of these agents is sometimes used to treat **detrusor overactivity** by initially stimulating and then "desensitizing" the sensory afferents (C-fibers). * **C-Fibers vs. A-delta Fibers:** Normal bladder filling is sensed by A-delta fibers. However, in pathological states (like spinal cord injury or inflammation), the **TRPV1-expressing C-fibers** become hyper-excitable, leading to urgency and frequency. * **Location:** TRPV1 receptors are also highly expressed in the **urothelium**, which acts as a sensory organ communicating with underlying nerves via ATP release.
Explanation: **Explanation:** The correct answer is **C. Indirectly in the proximal convoluted tubule**. **1. Why Option C is Correct:** Approximately 80–90% of filtered bicarbonate ($HCO_3^-$) is reabsorbed in the **Proximal Convoluted Tubule (PCT)**. However, the luminal membrane of the PCT is impermeable to bicarbonate ions. Reabsorption occurs **indirectly** through the following mechanism: * $H^+$ ions are secreted into the lumen (via $Na^+/H^+$ exchanger). * In the lumen, $H^+$ combines with filtered $HCO_3^-$ to form $H_2CO_3$. * **Carbonic Anhydrase (Type IV)** on the brush border breaks $H_2CO_3$ into $CO_2$ and $H_2O$. * $CO_2$ diffuses freely into the cell, where **Carbonic Anhydrase (Type II)** converts it back into $H^+$ and $HCO_3^-$. * The $HCO_3^-$ then exits the basolateral membrane into the blood via the $Na^+/HCO_3^-$ cotransporter. Because it must first be converted to $CO_2$ to cross the membrane, the process is termed "indirect." **2. Why Other Options are Incorrect:** * **Options A, B, and D:** Bicarbonate is not "actively" transported across the apical membrane as an ion; it requires the chemical conversion described above. While the Distal Convoluted Tubule (DCT) and collecting ducts do reabsorb the remaining 10–15% of bicarbonate (via Type A intercalated cells), the bulk of reabsorption happens in the PCT. **3. NEET-PG High-Yield Pearls:** * **Carbonic Anhydrase Inhibitors (Acetazolamide):** These drugs act primarily in the PCT, blocking this indirect reabsorption and leading to alkaline urine and metabolic acidosis. * **Rate-Limiting Step:** The secretion of $H^+$ into the lumen is the primary driver for $HCO_3^-$ reabsorption. * **Site Summary:** PCT (85%) > Thick Ascending Limb (10%) > Distal Tubule/Collecting Duct (5%).
Explanation: **Explanation:** The correct answer is **JG cell (Juxtaglomerular cell)**. **1. Why JG cells are correct:** JG cells are modified smooth muscle cells located primarily in the afferent arteriole. Their primary function is **secretory**; they synthesize, store, and release the enzyme **renin** into the bloodstream. Renin is the rate-limiting step of the Renin-Angiotensin-Aldosterone System (RAAS), which regulates blood pressure and fluid balance. These cells act as baroreceptors, sensing changes in renal perfusion pressure. **2. Analysis of incorrect options:** * **P cells (Principal cells):** Found in the collecting ducts, these cells are primarily involved in **transport (reabsorption/secretion)** rather than glandular secretion. They reabsorb sodium and water and secrete potassium under the influence of aldosterone and ADH. * **I cells (Intercalated cells):** Also found in the collecting ducts, these cells are specialized for **acid-base regulation**. Type A cells secrete $H^+$ and reabsorb $HCO_3^-$, while Type B cells do the opposite. While they "secrete" ions, they are classified as transport cells, not secretory cells in the endocrine/enzymatic sense like JG cells. * **All of the above:** This is incorrect because the term "secretory function" in renal histology specifically highlights the glandular-like production of hormones/enzymes (Renin), which is unique to the JG cells in this context. **High-Yield Clinical Pearls for NEET-PG:** * **JG Apparatus components:** JG cells (modified smooth muscle), Macula Densa (modified DCT cells acting as chemoreceptors), and Lacis cells (extraglomerular mesangial cells). * **Stimuli for Renin release:** Decreased renal perfusion (baroreceptor), decreased NaCl delivery to macula densa, and Sympathetic stimulation ($\beta_1$ receptors). * **Erythropoietin (EPO):** Another key renal "secretion," but it is produced by **peritubular interstitial fibroblasts**, not the tubular cells.
Explanation: ### Explanation **1. Why Renogastric Reflex is Correct:** The **renogastric reflex** is a visceral autonomic reflex that explains the functional link between the kidneys and the stomach. When the kidney or ureter is irritated—most commonly due to **renal calculi (stones)** or inflammation—sensory afferent impulses are sent to the spinal cord. This triggers an inhibitory sympathetic response that decreases gastric motility and secretion. Clinically, this manifests as nausea, vomiting, and abdominal distension, which are hallmark gastrointestinal symptoms of renal colic. **2. Analysis of Incorrect Options:** * **A. Chemical reaction:** While uremia (accumulation of nitrogenous waste) in end-stage renal disease can cause "chemical" irritation of the gut lining (uremic gastritis), it is not the primary reflex mechanism for acute GI symptoms in general urinary diseases. * **C. Peritoneal reaction:** This occurs when the peritoneum is irritated (e.g., peritonitis or retroperitoneal hemorrhage). While severe renal inflammation can irritate the overlying peritoneum, it is a secondary anatomical consequence rather than the physiological mechanism governing the GI response. * **D. Reflux phenomenon:** This term usually refers to the backward flow of fluids (e.g., Vesicoureteral reflux or Gastroesophageal reflux) and does not describe a neural reflex causing multi-organ symptoms. **3. NEET-PG High-Yield Pearls:** * **Renointestinal Reflex:** Similar to the renogastric reflex, irritation of the kidney can inhibit intestinal peristalsis, leading to **paralytic ileus**. * **Nerve Supply:** The kidneys and the GI tract share common autonomic pathways (T10–L1 levels), which explains the **referred pain** and visceral cross-talk. * **Clinical Presentation:** Always consider renal stones in a patient presenting with acute "surgical abdomen" symptoms like vomiting and ileus if they also have loin pain or hematuria.
Renal Blood Flow and Glomerular Filtration
Practice Questions
Tubular Reabsorption and Secretion
Practice Questions
Concentration and Dilution of Urine
Practice Questions
Acid-Base Regulation by the Kidneys
Practice Questions
Sodium and Water Balance
Practice Questions
Potassium Regulation
Practice Questions
Calcium and Phosphate Handling
Practice Questions
Micturition Physiology
Practice Questions
Renal Function Tests
Practice Questions
Integrative Responses to Fluid Challenges
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free